ARCHIVES

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 17 | April 29, 1994

Download PDF Visit The Full Archive

Related Articles

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

NCI Has Congressional Mandate Fr Planning Clinical Trials of Unconventional Therapies, Chabner Says

June 5, 1992

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Citizens Committee Notes Broad Support For NCI Funds

August 24, 1979